GPCCMP

GP MANAGEMENT PLAN - Asthma ,Patient Details:, - Full Name: John Smith - Date of Birth: 12/03/1965 - Medicare Number: 1234567890 - Does the patient identify as Aboriginal or Torres Strait Islander: No - Address: 10 Downing Street, London, SW1A 2AA - Home Phone: 020 7946 0000 - Mobile Phone: 07700 900000 Date GPMP Completed: 01/11/2024 Date of Previous GPMP: 15/05/2023 Details of Patient's Usual GP: - Name: Dr. Jane Doe - Qualifications: MBBS, FRACGP - GP's Address: 12 Harley Street, London, W1G 9PF - GP's Phone: 020 7123 4567 - GP's Fax: 020 7123 4568 ,Assessment of Patient, Patient Identified Problems / Health Care Needs: - Diagnosis: Asthma - Date of Diagnosis: 10/06/2010 ,Medical / Surgical History:, Patient has a history of seasonal allergies and mild hypertension, managed with medication. ,Medications:, - Salbutamol inhaler 100mcg, 2 puffs as needed for breathlessness - Budesonide inhaler 200mcg, 2 puffs twice daily - Lisinopril 10mg once daily ,Allergies:, Patient reports allergy to penicillin, causing rash. ,Immunisation History:, Patient is up-to-date with influenza and pneumococcal vaccinations. ,Smoking History:, Patient is a non-smoker. ,Planned Review Date:, 01/05/2025 ,GPMP Added to the Patient’s Records:, Yes ,Copy of GPMP Offered to Patient:, Yes ,Patient Understanding and Agreement:, "I understand the Management Plan recommendations and agree to the outlined goals." Patient Signature: [Patient's signature] Date: 01/11/2024 "I have explained the steps and costs involved, and the patient has agreed to proceed with the service." GP Signature: [GP's signature] Date: 01/11/2024 ,Current Health Need/Problem:, Patient experiences occasional asthma exacerbations, particularly during seasonal changes. Current symptoms include mild shortness of breath and wheezing. ,Goal:, To reduce the frequency and severity of asthma exacerbations, improve lung function, and enhance the patient's quality of life. ,Agreed Action by Health Professionals and Patient, 1. ,General, - ,Patient's Understanding of the Condition:, Patient understands their asthma triggers and the importance of using their inhalers correctly. They have been provided with educational materials on asthma management. 2. ,Lifestyle, - ,Quality of Life:, Patient reports that their asthma occasionally impacts their daily activities. The Asthma Quality of Life Questionnaire (AQLQ) will be used to monitor the impact of asthma on their quality of life. - ,Nutrition:, Patient is encouraged to maintain a balanced diet. Referral to a dietitian is available if needed. - ,Physical Activity/Exercise:, Patient is encouraged to engage in regular physical activity, such as walking or swimming, as tolerated. They are advised to use their reliever inhaler before exercise if needed. - ,Smoking Cessation:, Patient is a non-smoker. Advice on avoiding exposure to smoke is provided. 3. ,Biochemical, - ,Spirometry (or other relevant tests):, Spirometry will be performed every six months to monitor lung function. The FEV1/FVC ratio will be monitored. 4. ,Medication, - ,Medication Review:, Medications will be reviewed at each follow-up appointment to ensure correct usage and address any side effects. The patient is educated on the proper use of their inhalers. - ,Immunisation:, Patient is up-to-date with influenza and pneumococcal vaccinations. 5. ,Complications, - ,Monitoring of Health Conditions:, Patient is advised to monitor their symptoms and seek medical attention if symptoms worsen. They are educated on the signs of an asthma exacerbation. 6. ,Mental Health and Wellbeing, - ,Depression, Anxiety, and Stress:, Patient will be assessed for signs of depression, anxiety, or stress at each review. Referral to a psychologist is available if needed. - ,Social Support and Isolation:, Patient is encouraged to participate in social activities and support networks to reduce isolation and improve emotional well-being. Contact details for local asthma support groups are provided.